Department of Health (DOH) announces that Chinese Sinovac Firm who developed Sinovac Covid19 vaccine was allowed by the government to undertake clinical trials procedure on the identified population in Philippines before launching
According to health secretary Maria Vergerie, identified sectors to be tested by sinovac vaccine are placed into secrecy and she’s not permitted to disclose any names since it is under with the Department of Science and Technology
”Pero ang intention natin kaya gustong ituloy yan kahit nag-apply na siya (Sinovac) ng EUA because they want to try it on a specific population para makita natin ang epekto among us Asians and this specific group of population”-Vergerie said
Chinese sinovac vaccine developer is already taken action for Emergency Use Authorization (EUA) approval
Meanwhile, in order for develop covid-19 vaccine to enter into Philippines or to other countries, it must pass the following procedures
First, by conducting a study though clinical trial procedure
And second, approve by Emergency Use Authorization (EUA) that allows FDA or vaccine to be reliable to purchased by the national government for vaccination program
Sinovac vaccine received approval from FDA last January 15, 2021
The Chinese Sinovac Firm is the first vaccine developer expected to supply covid 19 vaccines to the country with over 25 million doses